LABORATORY SERVICES AGREEMENTLaboratory Services Agreement • June 30th, 2009 • Rosetta Genomics Ltd. • Pharmaceutical preparations
Contract Type FiledJune 30th, 2009 Company IndustryThis Laboratory Services Agreement (“Agreement”) is made and entered into effective as of April 10, 2009, (the “Effective Date”) by and between Rosetta Genomics Inc., a corporation organized under the laws of Delaware, having a principal place of business at 3711 Market St., Suite 740, Philadelphia, PA, 19104 (“Rosetta”), and Prometheus Laboratories Inc., a California corporation, having its principal place of business at 9410 Carroll Park Drive, San Diego, CA 92121 USA (“Prometheus”). Rosetta and Prometheus each may be referred to herein as a “Party” or collectively as the “Parties”.
License Agreement by and between Prometheus Laboratories Inc. and Rosetta Genomics Ltd. April 10, 2009License Agreement • June 30th, 2009 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJune 30th, 2009 Company Industry JurisdictionThis License Agreement (“Agreement”) is entered into as of April 10, 2009 (the “Execution Date”), and is by and between Prometheus Laboratories Inc., a California corporation having its principal place of business at 9410 Carroll Park Drive, San Diego, CA 92121 USA (“Prometheus”) and Rosetta Genomics Ltd., a corporation organized under the laws of Israel, having its principal place of business at 10 Plaut St., Rehovot, Israel, 76706 (“Rosetta”).
EXCLUSIVE TESTING AND ADMINISTRATIVE SERVICES AGREEMENT between ROSETTA GENOMICS LTD. A limited liability company under the laws of Israel, of 10 Plaut St., Rehovot, Israel, 76706 (“Rosetta”) and TEVA PHARMACEUTICAL INDUSTRIES LTD. of P.O. Box 3190...Exclusive Testing and Administrative Services Agreement • June 30th, 2009 • Rosetta Genomics Ltd. • Pharmaceutical preparations
Contract Type FiledJune 30th, 2009 Company IndustryTHIS EXCLUSIVE TESTING AND ADMINISTRATIVE SERVICES AGREEMENT (this “Agreement”) is made as of the 24th day of December, 2008, by and between: Rosetta, Ltd., through its offices located at 10 Plaut St., Rehovot, Israel, 76706 (“Rosetta”); and Teva Pharmaceutical Industries Ltd., through its offices located at 12 Hatrufa St., Netanya, Israel (“Teva”).